(19)
(11) EP 0 661 996 A1

(12)

(43) Date of publication:
12.07.1995 Bulletin 1995/28

(21) Application number: 93900577.0

(22) Date of filing: 18.11.1992
(51) International Patent Classification (IPC): 
A61K 38/ 00( . )
A61K 39/ 00( . )
A61K 47/ 48( . )
A61P 37/ 00( . )
C07K 14/ 47( . )
C07K 14/ 74( . )
G01N 33/ 564( . )
A61K 31/ 70( . )
A61K 39/ 385( . )
A61P 29/ 00( . )
C07K 1/ 113( . )
C07K 14/ 705( . )
G01N 33/ 53( . )
(86) International application number:
PCT/US1992/010031
(87) International publication number:
WO 1993/009810 (27.05.1993 Gazette 1993/13)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE

(30) Priority: 19.11.1991 US 19910793938

(71) Applicant: ANERGEN, INC.
Redwood City, CA 94063 (US)

(72) Inventors:
  • NAG, Bishwajit
    Pacifica, CA 94044 (US)
  • CLARK, Brian, R.
    Redwood City, CA 94061 (US)
  • SHARMA, Somesh, D.
    Os Altos, CA 94022 (US)
  • MCCONNEL, Harden, M.
    Stanford, CA 94305 (US)

(74) Representative: Armitage, Ian Michael, et al 
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) MHC SUBUNIT CONJUGATES USEFUL IN AMELIORATING DELETERIOUS IMMUNE RESPONSES